Loading clinical trials...
Loading clinical trials...
Blepharospasm Patient Survey: A Structured Interview Evaluating Previous and Current incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA Treatment for Patients With Blepharospasm
Conditions
Interventions
No intervention- only one time survey
Locations
5
United States
Merz Investigative Site #0007
Fountain Valley, California, United States
Merz Investigative Site # 0002
Sarasota, Florida, United States
Merz Investigative Site # 0001
Boston, Massachusetts, United States
Merz Investigative Site #003
Durham, North Carolina, United States
Merz Investigative Site # 0006
Columbus, Ohio, United States
Start Date
September 1, 2012
Primary Completion Date
April 1, 2013
Completion Date
April 1, 2013
Last Updated
October 28, 2022
NCT07489430
NCT03938363
NCT03903341
NCT02577224
NCT04423341
NCT04618887
Lead Sponsor
Merz Pharmaceuticals GmbH
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions